Cargando…
Management of hepatitis B virus reactivation due to treatment of COVID-19
The world has made significant progress in developing novel treatments for COVID-19 since the pandemic began. Some treatments target the patient’s dysregulated inflammatory response during COVID-19 infection and may cause hepatitis B reactivation (HBVr) in patients with current or past hepatitis B v...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer India
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889512/ https://www.ncbi.nlm.nih.gov/pubmed/35235148 http://dx.doi.org/10.1007/s12072-022-10306-x |